Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Y.L. Krasnaya
The Results of an Open Comparative Study in Parallel Groups of the Efficacy and Safety of the Refnot® (Tumor Necrosis Factor - Thymosin - 1 Alpha Recombinant) Drug in the Treatment of Disseminated Triple Negative Breast Cancer
Medicina
Related publications
The POSSIBILITY OF USING TUMOR NECROSIS FACTOR-THYMOSIN-α1 IN NEOADJUVANT CHEMOTHERAPY OF BREAST CANCER
Medical Council
The Efficacy of Betulinic Acid in Triple-Negative Breast Cancer
SAGE Open Medicine
Medicine
Treatment With Recombinant Human Tumor Necrosis Factor-Alpha Protects Rats Against the Lethality, Hypotension, and Hypothermia of Gram-Negative Sepsis.
Journal of Clinical Investigation
Medicine
The Efficacy of Andrographolide and Its Combination With Betulinic Acid in the Treatment of Triple Negative Breast Cancer
Cancer therapy & Oncology International Journal
The Role of Epidermal Growth Factor Receptor (EGFR) in the Efficacy of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients
Bulletin of Siberian Medicine
Molecular Medicine
Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer
Cell Reports
Biochemistry
Genetics
Molecular Biology
The Study of the Efficacy and Safety of Tonsilgon® N in the Treatment of Chronic Pharyngitis
Medical Council
Long-Term Efficacy and Safety of Exemestane in the Treatment of Breast Cancer
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Cetuximab-Conjugates Nanoparticles for the Treatment of Triple Negative Breast Cancer
